Anne Wojcicki's bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. That means Wojcicki's nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe's assets for $305 million.

A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led by the company's former CEO Anne Wojcicki, the company announced. The 23andMe bankruptcy earlier this year elicited fears about the security of genetic data belonging to the company's roughly 15 million customers.